Pharmagreen Biotech Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHBI research report →
Price Chart
About the company
Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.
- CEO
- Peter Wojcik
- IPO
- 2018
- HQ
- Coquitlam, BC, CA
Get TickerSpark's AI analysis on PHBI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $115.45K
- P/E
- -0.08
- PEG
- 0.00
- P/S
- 0.03
- P/B
- -0.01
- EV/EBITDA
- -0.12
- Div Yield
- 0.00%
- Gross Margin
- -0.02%
- Op Margin
- -31.60%
- Net Margin
- -29.06%
- ROE
- 21.06%
- ROIC
- 14.97%
Latest fiscal year · YoY change
- Revenue
- $2.39K-30.0%
- Gross Profit
- $-400-123.0%
- Op Income
- $-290,493
- Net Income
- $406.36K+140.5%
- EPS
- $0.60+120.0%
- OCF Growth
- +17.0%
- FCF Growth
- +17.0%
- 52W High
- $7.00
- 52W Low
- $0.00
- 50D MA
- $1.69
- 200D MA
- $3.30
- Beta
- 1.75
- RSI (14)
- 25
- Avg Volume
- 373
No earnings-call transcripts are available for PHBI yet.
- Free Float
- 90.4%
- Shares Outstanding
- 345.67K
- Float Shares
- 312.59K
Our PHBI coverage
Recent articles, reports, and earnings notes.
No research on PHBI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHBI report →Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its Project
globenewswire.com · Oct 10
Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress
globenewswire.com · Sep 19
PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its' Nutraceutical Formulations
accesswire.com · Jan 24
Pharmagreen Provides Update on Funding and Acquisition Progress
newsfilecorp.com · Sep 29
Pharmagreen Signs MOU to Acquire a California Based Cannabis Company
newsfilecorp.com · Aug 12
Pharmagreen Provides Company Update For Its Shareholders
globenewswire.com · Apr 28
Pharmagreen Extends the Letter of Intent Timeline with Advanced Bio-Oil Technologies Ltd.
globenewswire.com · Apr 19
10 Penny Stocks That You Can Have for Less Than a Dime
investorplace.com · Feb 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.